Riskpilot← Back to searchSign inGet full accessColoplast Holding ApS
APSActiveCVR 44242648Hammerensgade 1, 3.Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2023— employees
Revenue 2025
—
EBITDA margin
—
+59% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK 1,5B
+5% vs 2024
| Revenue | — | — |
| EBITDA | DKK -310K | +59% |
| Net profit | DKK 1,5B | +5% |
| Total assets | DKK 2,6B | +0% |
| Equity | DKK 2,6B | +0% |
| Employees | — | — |
Legal name
Coloplast Holding ApS
CVR number
44242648
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
17. august 2023
Share capital
DKK 67.302.517
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er, direkte eller indirekte, at eje kapitalandele i Coloplast A/S, CVR nr. 69 74 99 17, og derigennem understøtte Coloplast A/S langsigtede udvikling.
Address
Hammerensgade 1, 3.
Phone
+4549184027
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | — | — | — |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -92 | -753 | -310 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -92 | -753 | -310 |
| Net financials | 121 | 1.414.148 | 1.480.987 |
| Profit before tax | 29 | 1.413.395 | 1.480.677 |
| Tax | 7 | 99 | 5 |
| Net profit | 22 | 1.413.295 | 1.480.672 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 2.618.888 | 2.620.511 | 2.620.474 |
| Equity | 2.618.790 | 2.620.233 | 2.620.249 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 98 | 278 | 225 |
| Total debt | 98 | 278 | 225 |
EBITDA margin
-31000000.0%
This company
15.8%
Market median
-196202632% vs market
20232025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232025
Return on equity
56.5%
This company
18.4%
Market median
+207% vs market
20232025
Net profit margin
148067200000.0%
This company
8.1%
Market median
+1827990123357% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NM Management | Management | 2023 | — | — |
LS Management | Management | 2023 | — | — |
HD Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NPLH Holding ApS | Company | 50.0% | 66.7% | 2023 |
Aage og Johanne Louis-Hansen A/S | Company | 33.3% | 25.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AAGE OG JOHANNE LOUIS-HANSENS FONDAage og Johanne Louis-Hansen A/S
Coloplast Holding ApS (this company)Board members of Coloplast Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Mazanti | Management | 0 companies |
| Lars Stig Kongsgaard Hansen | Management | 0 companies |
| Henrik Dahl | Management | 0 companies |
| Michael Pram Rasmussen | Board of Directors | 0 companies |
| Niels Peter Louis-Hansen | Chairman | 0 companies |
| Gerda Louis-Hansen | Board of Directors | 0 companies |
| Marianne Kirstine Louis-Hansen | Board of Directors | 0 companies |